Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
123.61B | 124.76B | 119.82B | 122.00B | 121.93B | 138.49B | Gross Profit |
25.09B | 25.22B | 22.36B | 21.31B | 25.66B | 22.22B | EBIT |
7.00B | 7.00B | 4.55B | 2.63B | 7.45B | 4.92B | EBITDA |
12.32B | 19.54B | 10.80B | 8.23B | 12.72B | 9.75B | Net Income Common Stockholders |
10.07B | 10.29B | 3.66B | 2.01B | 6.17B | 6.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
21.32B | 24.25B | 23.58B | 24.76B | 26.35B | 36.65B | Total Assets |
197.52B | 196.78B | 194.85B | 192.76B | 196.71B | 197.72B | Total Debt |
20.98B | 21.04B | 25.28B | 31.00B | 32.91B | 42.70B | Net Debt |
-337.00M | -3.21B | 3.85B | 6.24B | 6.57B | 6.05B | Total Liabilities |
69.58B | 66.28B | 75.69B | 78.47B | 86.22B | 94.06B | Stockholders Equity |
125.68B | 128.01B | 116.75B | 112.06B | 108.45B | 101.90B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.27B | 4.48B | -2.24B | -252.00M | 4.26B | Operating Cash Flow |
0.00 | 4.17B | 9.02B | 3.00B | 7.58B | 11.52B | Investing Cash Flow |
0.00 | 1.42B | -1.45B | -2.19B | -6.64B | -3.77B | Financing Cash Flow |
0.00 | -7.00B | -10.21B | -3.84B | -11.42B | -358.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥55.26B | 13.52 | 3.18% | 6.36% | 17.44% | ||
79 Outperform | ¥59.80B | 7.85 | 2.16% | 5.44% | 8.53% | ||
79 Outperform | ¥54.93B | 5.10 | 4.91% | 4.12% | 192.18% | ||
75 Outperform | ¥73.08B | 8.32 | 4.65% | 4.87% | 5.12% | ||
71 Outperform | ¥43.40B | 8.33 | 5.63% | 3.16% | ― | ||
66 Neutral | ¥60.06B | 9.65 | 4.60% | 3.21% | -1.94% | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |